Search Results

Advanced age-related macular degeneration (AMD) is often bilateral and most prevalent in patients over age 60.1,2 AMD is considered end-stage when visual impairment resulting from bilateral central scotomas and/or disciform scars is moderate to profound. Treatment options for patients with end-stage AMD are extremely limited. As a result, patients with end-stage AMD have a severely […]

Ghana lies in the center of the West African coast, bordered on the south by the Gulf of Guinea and the Atlantic Ocean, between Ivory Coast to the west and Togo to the east. Its southernmost point is Cape Three Points, 4° 30’ N of the equator, from where it extends inland to latitude 11° […]

In this expert Q&A, we speak with Dr Samir Jabbour, Assistant Clinical Professor at the University of Montreal and Adjunct Clinical Professor at McGill University, who also practices at the Centre hospitalier de l'Université de Montréal (CHUM) and Jewish General Hospital (JGH). Dr Jabbour shares insights from his presentation on the evolving role of combining refractive procedures with corneal crosslinking (CXL) for patients with keratoconus and post-refractive ectasia. He discusses clinical indications, patient selection, benefits and risks of simultaneous versus sequential approaches, and the technologies driving the next wave of personalized corneal treatments.

Age-related macular degeneration (AMD) is the most common cause of irreversible visual loss in the western world.1–5 Broadly, there are two types of AMD: dry or non-exudative AMD, and wet or exudative AMD. The dry form is characterised by drusen formation and a slow, progressive focal atrophy of the macular retinal pigment epithelium (RPE) and […]

Descemet-stripping automated endothelial keratoplasty (DSAEK) has become the procedure of choice to treat corneal endothelial dysfunction. Developed by Melles et al.1 and modified by others,2 DSAEK evolved from posterior lamellar keratoplasty (PLK) and deep lamellar endothelial keratoplasty (DLEK). The host Descemet membrane is removed and a graft consisting of posterior stroma, Descemet membrane, and endothelial […]

Descemet’s stripping automated endothelial keratoplasty (DSAEK) has become the procedure of choice to treat corneal endothelial dysfunction. Developed by Melles et al.1 and modified by others,2 DSAEK evolved from posterior lamellar keratoplasty (PLK) and deep lamellar endothelial keratoplasty (DLEK). The host Descemet’s membrane is removed and a graft consisting of posterior stroma, Descemet’s membrane and […]

Traumatic brain injury (TBI) is the signature injury of the conflicts in Iraq and Afghanistan. The Department of Defense defines mild traumatic brain injury by loss of consciousness for up to 30 minutes, or an alteration in mental state and/or memory loss, which lasts less than 24 hours and structural brain imaging yielding normal results.1 […]

End-stage AMD—Clinical Challenge withNew Option for Visual Rehabilitation Age-related macular degeneration (AMD) is a leading cause of vision loss with approximately 200,000 new diagnoses of its neovascular form each year in the US alone.1 Fortunately, many of these patients benefit from antivascular endothelial growth factor (anti-VEGF) pharmaceutical treatments, and such management has changed the epidemiology […]